Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 25 2022 - 4:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of April 2022
Commission File Number: 001-38281
ERYTECH Pharma S.A.
(Translation of registrants name into English)
60 Avenue
Rockefeller
69008 Lyon France
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INCORPORATION BY REFERENCE
This Report on Form 6-K and Exhibit 99.1 to this Report on
Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (File Nos.
333-248953 and 333-259690) and registration statements on Form S-8 (File Nos. 333-222673,
333-232670, 333-239429 and 333-255900), of ERYTECH Pharma S.A. (the Company) (including any prospectuses forming
a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Press Release
On April 25, 2022, ERYTECH Pharma
S.A. (the Company) issued a press release announcing the disposition of certain assets and inventory to Catalent Princeton, LLC pursuant to an asset purchase agreement. A copy of the press release is attached to this Form 6-K as Exhibit 99.1.
EXHIBITS
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
ERYTECH Pharma S.A. |
|
|
|
Date: April 25, 2022 |
|
By: |
|
/s/ Eric Soyer |
|
|
|
|
Name |
|
Eric Soyer |
|
|
|
|
Title: |
|
Chief Financial Officer and Chief Operating Officer |
Erytech Pharma (NASDAQ:ERYP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Erytech Pharma (NASDAQ:ERYP)
Historical Stock Chart
From Apr 2023 to Apr 2024